tiprankstipranks
Trending News
More News >
Barinthus Biotherapeutics (BRNS)
NASDAQ:BRNS
US Market

Barinthus Biotherapeutics (BRNS) Income Statement

Compare
91 Followers

Barinthus Biotherapeutics Income Statement

Last quarter (Q4 2024), Barinthus Biotherapeutics's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, Barinthus Biotherapeutics's net income was $-20.53M. See Barinthus Biotherapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 14.97M$ 802.00K$ 44.70M$ 268.00K$ 4.82M
Gross Profit
$ 14.97M$ 802.00K$ 44.70M$ 268.00K$ 4.82M
Operating Expenses
$ 82.94M$ 84.72M$ 47.50M$ 41.49M$ 21.59M
Depreciation and Amortization
$ 5.80M$ 5.45M$ 5.54M$ 601.93K$ 210.02K
EBITDA
$ -55.37M$ -71.06M$ 6.40M$ -47.86M$ -14.14M
Operating Income
$ -67.97M$ -83.91M$ -4.04M$ -45.22M$ -20.05M
Other Income/Expenses
$ 6.74M$ 7.39M$ 4.89M$ -5.92M$ 2.21M
Pretax Income
$ -61.23M$ -76.52M$ 850.00K$ -51.14M$ -17.84M
Net Income
$ -61.07M$ -73.35M$ 5.34M$ -50.87M$ -17.71M
Per Share Metrics
Basic EPS
$ -1.55$ -1.91$ 0.14$ -1.37$ -371.62
Diluted EPS
$ -1.55$ -1.91$ 0.14$ -1.37$ -371.62
Weighted Average Shares Outstanding
39.35M 38.39M 37.25M 37.19M 47.65K
Weighted Average Shares Outstanding (Diluted)
39.35M 38.39M 38.17M 37.19M 47.65K
Currency in USD

Barinthus Biotherapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis